Published in Int J Radiat Oncol Biol Phys on May 01, 2003
Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) (2012) 2.67
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys (2007) 2.55
Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol (2011) 2.05
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol (2008) 1.89
Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol (2010) 1.70
Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer (2011) 1.55
Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg (2004) 1.53
Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A (2005) 1.52
Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer (2004) 1.51
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys (2007) 1.50
Production and killing of second cancer precursor cells in radiation therapy: in regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88). Int J Radiat Oncol Biol Phys (2004) 1.45
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol (2013) 1.32
Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol (2010) 1.32
Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer. Radiat Oncol (2010) 1.25
Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms. Phys Med Biol (2008) 1.25
Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys (2012) 1.24
Comparative effectiveness of external-beam radiation approaches for prostate cancer. Eur Urol (2012) 1.17
A dosimetric analysis of 6 MV versus 15 MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix. Rep Pract Oncol Radiother (2010) 1.17
Monte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validation. Phys Med Biol (2009) 1.15
Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique. Radiother Oncol (2014) 1.09
Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays? Radiat Oncol (2011) 1.05
Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br J Radiol (2012) 1.05
Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol (2006) 1.04
Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys (2005) 1.03
Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiother Oncol (2010) 1.03
What is an acceptably smoothed fluence? Dosimetric and delivery considerations for dynamic sliding window IMRT. Radiat Oncol (2007) 1.03
Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiat Oncol (2011) 1.02
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT). Radiat Oncol (2009) 1.02
Recent advancements in multimodality treatment of gliomas. Future Oncol (2011) 1.02
Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model (2011) 1.01
High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy. Br J Radiol (2009) 1.00
Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol (2011) 1.00
Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets. Radiat Oncol (2010) 0.99
Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy. J Med Phys (2011) 0.98
Radiation-induced sarcomas of the head and neck. World J Clin Oncol (2014) 0.98
A feasibility study to calculate unshielded fetal doses to pregnant patients in 6-MV photon treatments using Monte Carlo methods and anatomically realistic phantoms. Med Phys (2008) 0.97
Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol (2013) 0.96
Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT. Radiol Oncol (2012) 0.96
Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Med Phys (2012) 0.95
Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat Environ Biophys (2007) 0.95
Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol (2008) 0.94
The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid (2013) 0.93
On the performances of Intensity Modulated Protons, RapidArc and Helical Tomotherapy for selected paediatric cases. Radiat Oncol (2009) 0.93
Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification. Radiat Oncol (2012) 0.93
Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Lung Cancer (2013) 0.93
Treatment planning and dosimetric comparison study on two different volumetric modulated arc therapy delivery techniques. Rep Pract Oncol Radiother (2012) 0.92
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol (2012) 0.91
Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer. Int J Clin Oncol (2011) 0.91
Prostatic sarcoma after treatment of rectal cancer. World J Surg Oncol (2007) 0.90
The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future. Rep Pract Oncol Radiother (2013) 0.90
Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy. Strahlenther Onkol (2009) 0.90
Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom. Phys Med Biol (2009) 0.89
Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol (2011) 0.88
Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature. Radiat Oncol (2009) 0.87
MRI of radiation-induced tumors of the head and neck in post-radiation nasopharyngeal carcinoma. Eur Radiol (2009) 0.87
Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol (2013) 0.87
Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol (2012) 0.87
Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol (2014) 0.86
Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol (2013) 0.86
Treating prostate cancer with radiotherapy. Nat Rev Clin Oncol (2010) 0.86
A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer. J Med Radiat Sci (2013) 0.86
High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma. Radiat Oncol (2012) 0.86
On the performances of different IMRT Treatment Planning Systems for selected paediatric cases. Radiat Oncol (2007) 0.85
Static versus dynamic intensity-modulated radiotherapy: Profile of integral dose in carcinoma of the nasopharynx. J Med Phys (2009) 0.85
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy. Radiat Oncol (2013) 0.85
Proton radiotherapy for solid tumors of childhood. Technol Cancer Res Treat (2012) 0.85
Altered composition of bone as triggered by irradiation facilitates the rapid erosion of the matrix by both cellular and physicochemical processes. PLoS One (2013) 0.85
Is there a place for quantitative risk assessment? J Radiol Prot (2009) 0.85
The impact of flattening-filter-free beam technology on 3D conformal RT. Radiat Oncol (2013) 0.85
A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiat Oncol (2012) 0.85
Current status of IMRT in head and neck cancer. Rep Pract Oncol Radiother (2013) 0.85
Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiat Oncol (2013) 0.85
Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms. Radiat Oncol (2013) 0.84
Intensity modulated radiotherapy: advantages, limitations and future developments. Biomed Imaging Interv J (2006) 0.84
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol (2013) 0.84
Radiation therapy for children: evolving technologies in the era of ALARA. Pediatr Radiol (2008) 0.84
Intensity-modulated radiation therapy: emerging cancer treatment technology. Br J Cancer (2005) 0.84
A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse. Radiat Oncol (2014) 0.84
Quasi-IMAT technique and secondary cancer risk in prostate cancer. Strahlenther Onkol (2009) 0.84
The Feasibility Study of a Hybrid Coplanar Arc Technique Versus Hybrid Intensity-modulated Radiotherapy in Treatment of Early-stage Left-sided Breast Cancer with Simultaneous-integrated Boost. J Med Phys (2017) 0.83
Minimizing second cancer risk following radiotherapy: current perspectives. Cancer Manag Res (2014) 0.83
Performance evaluation of an algorithm for fast optimization of beam weights in anatomy-based intensity modulated radiotherapy. J Med Phys (2010) 0.82
Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma. Radiat Oncol (2014) 0.82
Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques. Radiat Oncol (2015) 0.82
Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique. Br J Radiol (2014) 0.82
Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method. PLoS One (2015) 0.82
Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes. Proteomics (2009) 0.81
Factors associated with nodal metastasis in nasopharyngeal cancer: an approach to reduce the radiation field in selected patients. Br J Radiol (2010) 0.81
Technical advances and pitfalls in head and neck radiotherapy. J Oncol (2012) 0.80
Evaluation of the trade-offs encountered in planning and treating locally advanced head and neck cancer: intensity-modulated radiation therapy vs dual-arc volumetric-modulated arc therapy. Br J Radiol (2012) 0.80
CT and MRI findings of radiation-induced external auditory canal carcinoma in patients with nasopharyngeal carcinoma after radiotherapy. Br J Radiol (2015) 0.80
A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol (2013) 0.80
Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control (2013) 0.80
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol (2011) 0.80
Microdosimetric measurements in the secondary radiation field produced in (12)C-therapy irradiations. Radiat Environ Biophys (2010) 0.79
Comparison of Head Scatter Factor for 6MV and 10MV flattened (FB) and Unflattened (FFF) Photon Beam using indigenously Designed Columnar Mini Phantom. J Med Phys (2014) 0.79
Performance of a commercial optical CT scanner and polymer gel dosimeters for 3-D dose verification. Med Phys (2004) 1.67
Determining optimal gel sensitivity in optical CT scanning of gel dosimeters. Med Phys (2003) 1.26
Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer. Brachytherapy (2002) 0.88
Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer J (2006) 0.83
Sensitivity calibration procedures in optical-CT scanning of BANG 3 polymer gel dosimeters. Med Phys (2010) 0.81
Optical computed tomography utilizing a rotating mirror and Fresnel lenses: operating principles and preliminary results. Phys Med Biol (2013) 0.79
Recommended ethics curriculum for medical physics graduate and residency programs: report of Task Group 159. Med Phys (2010) 0.78
A field size specific backscatter correction algorithm for accurate EPID dosimetry. Med Phys (2010) 0.77
Implementation of EPID transit dosimetry based on a through-air dosimetry algorithm. Med Phys (2012) 0.76
Performance of an improved first generation optical CT scanner for 3D dosimetry. Phys Med Biol (2013) 0.75
Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy. J Neurooncol (2014) 0.75